Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare
|
|
- Robyn Wright
- 6 years ago
- Views:
Transcription
1 Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare
2 Declaration of Competing Interests I have not received a fee for this talk today I have not received fees for consulting I have not received research funding I have not been employed by a pharma company I do not hold stocks or shares in any company which might be affected by my talk today I have not received funds reimbursing me for attending a related symposia, or talk
3 Learning Aims Introduction to UKMEC 2016 What s changed? Updates on current methods and choices How can we improve contraception advice and provision? Quick Starting Extended Regimens Exciting new methods in the pipeline! Your questions answered
4 What s the connection?
5 The Ideal Contraceptive Method The one that the person wants Method that works well Minimal negative effects Non-contraceptive benefits Does not interfere with sex Easy to use, minimal person participation Not too expensive
6 Contraceptive Options LARCs Etonogestrel implant Progestogen-only injections Levonorgestrel intrauterine systems Copper intrauterine devices Other methods Natural methods Male & female condoms Diaphragm/Cap Spermicides Oral contraceptives Combined oral contraceptive (COC) Progestogen-only pill (POP) Other combined methods Contraceptive patch Vaginal ring Permanent methods Male & female sterilisation
7 UK MEC 2016
8 Major Changes to UKMEC16 Change of format: LARC, medium, short-term method Removal of split categories Barrier methods, fertility awareness and sterilisation removed (see FSRH method-specific guidelines) Ulipristal acetate included in EHC Malaria, Raynaud s and schistosomiasis removed Obesity, organ transplant, long Q-T syndrome, rheumatoid arthritis included
9 What it does NOT do Does not replace clinical judgement, knowledge and skills Does not recommend or suggest a best method Does not replace a woman s choice Does not describe efficacy Does not provide advice about using method for noncontraceptive uses (e.g. bleeding control)
10 UKMEC16 Categories
11 Quick Starting what are you waiting for? With no current contraception and no risk of pregnancy Following emergency contraception With no current contraception and a risk of pregnancy Consider a bridging method FSRH Switching or Starting Methods of Contraception July 2016 Replaces FSRH Clinical Guidance Quick Starting Contraception 2010 FSRH Quick Starting after UPA September 2015
12 Reasonably certain? No intercourse since normal LMP Correct and consistent use of reliable method of contraception 7 days of LMP 4 weeks postpartum 7 days post-abortion or miscarriage LAM breastfeeding AND - negative pregnancy test AND - asymptomatic
13 Fixed Extended Regimens Seasonique 91 days Seasonale 84 days Lybrel days Available in USA Effective Increased risk of breakthrough bleeding Safety profiles similar to conventional regimens
14 Flexible Extended Regimens - CHC COCP, patch or ring Use continuously >21 days Until BTB for >3 days Then take 4-7 day break
15 Analysis of bleeding/spotting days in the comparative phase with ethinylestradiol 20 μg/drospirenone 3 mg administered as (a) flexiblemib, (b) conventional 28-day and (c) fixed extended regimens (full analysis set) Klipping C et al. J Fam Plann Reprod Health Care 2012;38:73-83 Copyright by the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists. All rights
16 Analysis of cycle length with ethinylestradiol 20 μg/drospirenone 3 mg administered as a flexible management of intracyclical (breakthrough) bleeding (MIB) regimen Klipping C et al. J Fam Plann Reprod Health Care 2012;38:73-83 Copyright by the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists. All rights
17 Sayana Press 104mg/0.65ml medroxyprogesterone acetate Self administered Subcutaneous injection 13 weeks +/- 1 week Annual review in clinic
18 What s in the pipeline? Lisvy Estelle Nesterone gel and ring Intrauterine ball - IUB Ment LNG + tenofovir Microchip
19 Lisvy Transdermal patch Clear Gestodene 60mcg/24 hours Ethinylestradiol 13mcg/24 hours
20 Estetra or Estelle Estretol (E4) Oestrogen produced by the fetal liver 3 rd phase trials with drosperinone Other uses for HRT Better tolerated Neutral effect on liver
21 Nesterone - segesterone acetate Long-acting vaginal ring Used in combination with EE Inserted for 21 days Removed for 7 days 1 ring last a year Refrigeration not required Phase 3 trials in US Transdermal gel Used in combination with estradiol Non-androgenic Better tolerated Fewer side effects Discrete Phase 2 trials in Chile
22 LNG and TFV Vaginal Ring Levonorgestrel 20mcg/24 hours Tenofovir 10mg/24 hours Contraceptive Reduce HIV transmission Reduce HSV transmission Under the woman s control Very early stages of development
23 Intrauterine ball Ocon Copper pearls on memory alloy 3 sizes 5 years duration Thread for removal More acceptable shape Reduced risk of perforation, expulsion and malposition
24 Ment Subdermal implant for men 7α-methyl-19- nortestosterone May be used with DMPA 1 year Suppress/inhibit sperm cell development Does not reduce libido Proof of concept stage
25 Contraceptive Microchip Levonorgestrel 30mcg/24 hours Implant in arm, buttocks or abdomen Switched on and off by the woman: no clinic visits Lasts up to 16 years Pre-clinical trials in US
26 Prescribing off-licence (label) sufficient evidence base and/or experience of using the medicine to demonstrate its safety and efficacy make a clear, accurate, legible record of all medicines prescribed where you are not following common practice, document your reasons for prescribing the medicine. General Medical Council Good Practice in Prescribing Medicines (2008)
27 Current and Common Practice It may not be necessary for clinicians to document every occasion when a contraceptive preparation is prescribed outside the product licence if such use falls within current guidance issued by the Faculty s Clinical Effectiveness Unit (CEU), the Royal College of Obstetricians and Gynaecologists (RCOG) and the National Institute for Health and Clinical Excellence (NICE); these should be regarded as common practice.
28 Nurse Prescribers The Nursing and Midwifery Council (NMC) advises RN or RM independent prescribers may prescribe off-label if they are satisfied that: this better serves the patient s/client s needs, if there is sufficient evidence-base and that they have explained to the patient/client the reasons why medicines are not licensed for their proposed use, and document accordingly. The NMC also states it is acceptable for medicines used outside the terms of the licence to be included in Patient Group Directions (PGDs) when such use is justified by current best clinical practice and the direction clearly describes the status of the product.
29 Any questions?
30 (01983)
Management of Emergency Contraception (EC)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Management of Emergency Contraception (EC) The risks and benefits of an IUD or oral EC should be discussed and documented (see appendix). Reasonable measures
More informationContraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital
Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception
More informationContraception for Adolescents: What s New?
Contraception for Adolescents: What s New? US Medical Eligibility Criteria for Contraceptive Use Kathryn M. Curtis, PhD Division of Reproductive Health, CDC Expanding Our Experience and Expertise: Implementing
More informationContraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE
Contraception Choices: An Evidence Based Approach Case Study Approach Susan Hellier PhD, DNP, FNP-BC, CNE Objectives Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC)
More informationWhat s New in Adolescent Contraception?
What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent
More informationTime Topic Speaker Abbreviation
1. Programme Sunday, 4 th November 2018 Time Topic Speaker Abbreviation 08:00 Welcome, distribution materials 08:30 Overview of the Medical Eligibility Criteria (2015), and the Selected Practices Recommendations
More informationthe IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to
your guide to Helping you choose the method of contraception that s best for you IUD IUD the e IUD IU IUD the IUD 2 3 The intrauterine device (IUD) An IUD is a small plastic and copper device that s put
More informationMedical Eligibility for Contraception Use
Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist
More informationLinda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit
Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit What We Plan To Do Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC) Explain
More informationMMPr001 EMERGENCY CONTRACEPTION PROTOCOL
MMPr001 EMERGENCY CONTRACEPTION PROTOCOL MMPr001 Emergency Contraception - (Sept18-Sept20) Page 1 of 8 Table of Contents MMPr001 EMERGENCY CONTRACEPTION PROTOCOL... 1 Why we need this protocol... 3 What
More informationOne-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire
One-day Essentials Contraception { Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire 80% women access contraception from their GP Therefore it is
More informationMMPr001 EMERGENCY CONTRACEPTION PROTOCOL
MMPr001 EMERGENCY CONTRACEPTION PROTOCOL Table of Contents MMPr001 EMERGENCY CONTRACEPTION PROTOCOL... 1 Why we need this Protocol... 2 What the Protocol is trying to do... 2 Which stakeholders have been
More informationContraceptives. Kim Dawson October 2010
Contraceptives Kim Dawson October 2010 Objectives: You will learn about: The about the different methods of birth control. How to use each method of birth control. Emergency contraception What are they?
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationExpanding Access to Birth Control: Will Women Get the Care They Need?
Expanding Access to Birth Control: Will Women Get the Care They Need? Target Audience: Pharmacists ACPE#: 0202-0000-18-045-L01-P Activity Type: Application-based Target Audience: ACPE#: Activity Type:
More informationPerimenopausal contraception: A practice-based approach
FOCUS Perimenopausal contraception: A practice-based approach Deborah Bateson, Kathleen McNamee Background Women who are perimenopausal are at risk of unintended pregnancy despite relatively low fertility
More informationlevonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer
levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises
More information2
1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive
More informationCONTRACEPTION OLD FRIENDS, NEW TRENDS
CONTRACEPTION OLD FRIENDS, NEW TRENDS AAP RECOMMENDATIONS 2014 1. Council about and ensure access to all contraceptive methods safe and appropriate describing most effective first. PEDIATRICS 134 (4)
More informationContraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016
Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Disclosure I am a Nexplanon trainer for Merck. Objectives Understand how obesity may affect pharmacokinetics
More informationEmergency contraception methods, including oral and
FOCUS Emergency contraception: Oral and intrauterine options Kirsten I Black, Safeera Y Hussainy Background Emergency contraception can be used to prevent pregnancy where contraception has not been used,
More informationContraception and gynecological pathologies
1 Contraception and gynecological pathologies 18 years old, 2 CMI normal First menstruation at 14 years old Irregular (every 2/3 months), painful + She does not need contraception She is worried about
More informationContraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014
Contraception Tami Allen, RNC OB, MHA Robin Petersen, RN, MSN Perinatal Clinical Nurse Specialist Objectives Discuss the impact of unintended pregnancy in the United States Discuss the risks and benefits
More informationInstruction for the patient
WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left
More informationPUBLIC HEALTH COMMUNINTY BASED SERVICES SERVICE SPECIFICATIONS
PUBLIC HEALTH COMMUNINTY BASED SERVICES SERVICE SPECIFICATIONS Service Specification No: Service: Authority Lead: CBS18-19(03) Provision of intrauterine device (IUD), intrauterine system (IUS) and sub-dermal
More informationThe Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH
The Doctor Is In Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria
More informationCODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40
CODING GUIDELINES FOR CONTRACEPTIVES Effective June 1, 2017 Version 1.40 TABLE OF CONTENTS ICD-10 CM Diagnosis Codes: Encounter for Contraception page 2 Coding for IUD Insertion and Removal Procedures
More informationLARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures
LARC: Long Acting Reversible Contraception Disclosures I have no relevant financial disclosures Jennifer Kerns, MD, MPH Assistant Professor, UCSF Obstetrics, Gynecology and Reproductive Sciences San Francisco
More informationTopics. Periods Menopause & HRT Contraception Vulva problems
Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per
More informationMDHHS: Coding and Billing for Contraceptive Services
1 The correct answer is B. A separate preventive E/M service was provided and a 25 modifier is necessary. The correct code is 99385 based on Lisa being new to the practice and being between 18 and 39 years
More informationContraception for young people. Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015
Contraception for young people Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015 Learning objectives Be able to apply the principles of confidentiality, Fraser Guidelines, consent and safeguarding
More informationRisk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare
Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare New data A paper published in May 2012 in the British Medical Journal
More informationPostpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION
Postpartum LARC (Long Acting Reversible Contraception) NURSING EDUCATION What is LARC Long-acting reversible contraception (LARC) methods include the intrauterine device (IUD) and the birth control implant.
More informationLearning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available
8:45 9:30 am Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin
More informationHormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics
Hormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics Advice from the Tayside Sexual & Reproductive Health Service (TSRHS) (Last update: 10/2017) Combined hormonal
More informationU.S. Medical Eligibility Criteria for Contraceptive Use, 2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 Division of Reproductive Health Centers for Disease Control and Prevention August 1, 2013 National Center for Chronic Disease Prevention and
More informationHIV and contraception the latest recommendations
1 8-11 June 2015, Chiang-Mai HIV and contraception the latest recommendations Mary Lyn Gaffield, Sharon Phillips, Rachel Baggaley, Petrus Steyn, and Marleen Temmerman 2 Medical eligibility criteria for
More informationfemale steri e sterilisation female sterilisation male and female sterilisation male sterilisation emale sterilisation female male sterilisati
your guide to male and female sterilisation Helping you choose the method of contraception that is best for you female sterilisati le sterilisation male sterilisation e sterilisation female female ster
More informationLearning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available
2:15 3pm Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin Batur,
More informationUnintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use
3:45 4:30 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationCLINICAL PEARLS IN CONTRACEPTION
CLINICAL PEARLS IN CONTRACEPTION Laura Borgelt, PharmD, FCCP, BCPS Associate Professor University of Colorado Denver PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as
More informationContraceptive Updates and Recommendations
Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,
More informationContraceptive Updates and Recommendations
Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,
More informationLEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common
4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationThe following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that
The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that may be used in the future Abstinence Choosing not to
More informationVCHIP LARC Needs Assessment Survey
VCHIP LARC Needs Assessment Survey Demographics 1. How many have you been in practice (post-training)? Choose one of the following answers 0-5 6-10 11-15 16-20 21 or more 2. What are your professional
More informationAn Overview of Long Acting Reversible Contraception Methods
An Overview of Long Acting Reversible Contraception Methods Unintended Pregnancy All pregnancies should be intended; that is, they should be consciously and clearly desired at the time of conception. -
More information1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis
1 2 3 1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet
More informationHIV/Sexual Health Clinical Education Session
HIV/Sexual Health Clinical Education Session http://courses.ashm.org.au/hiv/hiv-sexual-health-clinical-education-session/ About These Slide These slides may not be published, posted online, or used in
More informationWelcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.
Mirena is the #1 prescribed IUD * in the U.S. Welcome to Mirena The Mirena Handbook: A Personal Guide to Your New Mirena *Intrauterine Device Supported by 2015-2016 SHS data INDICATIONS FOR MIRENA Mirena
More informationDisclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck
ADOLESCENT CONTRACEPTION UPDATE APRIL 28, 2017 Brandy Mitchell, MN, RN, ANP BC, WHNP BC University of Iowa Hospitals and Clinics Obstetrics and Gynecology Iowa Association of Nurse Practitioners Spring
More informationThe Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.
The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings Counseling Cards Checklist to be reasonably sure a woman is not pregnant
More informationCLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR EMERGENCY HORMONAL CONTRACEPTION Levonorgestrel 1500mcg
CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR EMERGENCY HORMONAL CONTRACEPTION Levonorgestrel 1500mcg Version Control This document is only valid on the day it was printed The current version of this
More information100% Highly effective No cost No side effects
effective? Advantages Disadvantages How do I get Cost Abstinence For some it can mean no sexual contact. For others it is no sexual intercourse or vaginal penetration. A permanent surgical procedure available
More informationUpdate on EC methods and mechanism of action. Emergency Contraception (EC) Historical EC (1) Historical EC (2) Current EC Options
ESC Meeting 2016 Update on EC methods and mechanism of action Dr. Raymond Li MBBS, MMedSC, FRCOG, FHKAM (O&G) Cert RCOG/HKCOG (Reprod Med) Department of O&G, The University of Hong Kong The Family Planning
More informationReviewer No.2 Commentary: contraceptive medicines: does choice make a difference?
Reviewer No.2 Commentary: contraceptive medicines: does choice make a difference? The detailed review by Andrew Gray and colleagues (Systematic review of contraceptive medicines: does choice make a difference?
More information2
1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive
More informationSterilisation for women at the RD&E: what you need to know Reference Number: CW
Sterilisation for women at the RD&E: what you need to know Royal Devon and Exeter NHS Foundation Trust Patient Information Sterilisation for Women at The Royal Devon and Exeter Hospital What you need to
More informationLevosert levonorgestrel 20mcg/24hour intrauterine device
Levosert levonorgestrel 20mcg/24hour intrauterine device Verdict: Formulary inclusion: Formulary category: Restrictions: Reason for inclusion: Link to formulary: Link to medicine review summary: Levosert
More informationFDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)
FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) Mirena does not protect against HIV infection (AIDS) and other sexually transmitted infections
More informationDiscover the birth control you ve been looking for. Highly reliable. Virtually hassle-free. Totally hormone-free.
Discover the birth control you ve been looking for Highly reliable. Virtually hassle-free. Totally hormone-free. Over 70 million women worldwide use a nonhormonal IUC like ParaGard. Millions of women with
More informationArdhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
More informationPOLICY & PROCEDURE DEFINITIONS: N/A POLICY:
POLICY & PROCEDURE TITLE: Fertility Regulation Family Planning Scope/Purpose: To offer a wide range of approved methods for Family Planning services Division/Department: : All HealthPoint Clinics Policy/Procedure
More informationReview of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016
Review of IUCD Complications: Lessons from CAT Dr FG Mhlanga CAT Meeting 24 September 2016 INTRODUCTION The intrauterine device (IUD) is a reliable long term reversible, cost-effective,easy to use and
More informationFIGO and Prevention of Unsafe Abortion LARC and PM for PAC
FIGO and Prevention of Unsafe Abortion LARC and PM for PAC Dr. Anibal Faundes Second Regional Francophone West Africa PAC Meeting: Strengthening Postabortion Family Planning Saly, Senegal, October 6-11,
More informationWomen & Children's Business Unit Maternity Contraception and Sexual Health
Women & Children's Business Unit Maternity Contraception and Sexual Health Author/s Contact name Approval process Obstetric Guidelines Group/Associate Medical Director First Issue Date Trust intranet ref:
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Female Sterilisation Prior Approval Policy Date Adopted: 6 th February 2017 Version: 1617.1 Individual Funding Request Team - A partnership between Bristol,
More information28/09/2017. No conflict of interest. Unmet need for contraception. The Guideline Development Process. Learning objectives
ESC Date R H Se and mi n ar, place St. P e te rsb u rg Se pte mbe r 2 0 1 7 No conflict of interest New Highlights in the WHO Guidelines Family Planning /Contraception : Medical Eligibility Criteria MEC
More informationClinical Guidance: Drug Interactions with Hormonal Contraception
Clinical Guidance: Drug Interactions with Hormonal Contraception January 2018 FSRH Copyright Faculty of Sexual & Reproductive Healthcare January 2018 1 Drug Interactions with Hormonal Contraception Purpose
More informationBEST PRACTICES IN CONTRACEPTIVE COUNSELING
Condition Sub-condition Combined pill, patch, ring Anemias a) Thalassemia 1 1 1 1 1 2 b) Sickle cell disease 2 1 1 1 1 2 c) Iron-deficiency anemia 1 1 1 1 1 2 Benign ovarian (including cysts) 1 1 1 1 1
More informationMIDWIVES IN CONTRACEPTION AND FERTILITY PLANNING 15 TH ANNUAL SOMSA CONGRESS BLOEMFONTEIN AUGUST 2018
MIDWIVES IN CONTRACEPTION AND FERTILITY PLANNING 15 TH ANNUAL SOMSA CONGRESS BLOEMFONTEIN AUGUST 2018 Contraception is every health care workers responsibility # SOMSA Congress: Quality and Respectful
More informationUKMEC SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION
SUMMARY TABLE SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION Cu-IUD = Copper-bearing intrauterine device; LNG-IUS = Levonorgestrel-releasing intrauterine system; IMP = Progestogen-only implant;
More informationProgestogen only Contraception
Progestogen only Contraception Public Health Commissioned Service delivered by Community Pharmacies Jo Sutton Senior Commissioning Manager Long Term Care, Health and Treatment, Cheshire East Council Dr
More informationBirth Control- an Overview. Keith Merritt, MD. Remember, all methods of birth control are safer and have fewer side effects than pregnancy
Birth Control- an Overview Keith Merritt, MD Basics Remember, all methods of birth control are safer and have fewer side effects than pregnancy Even with perfect use, each method of birth control has a
More informationPercentage of family planning clinics, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and 2015
TABLE 1 Percentage of family planning, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and Clinic characteristics 2010 Yes No Focuses on reproductive
More informationInternational Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION
More informationMaximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community
Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community Reproductive Health 2012 September 21, 2012 David Turok, MD/MPH Objectives Communicate to colleagues the reduction
More informationChoose what. you use. The FPA essential guide to contraception. With foreword by Davina McCall
Choose what you use The FP essential guide to contraception With foreword by Davina McCall Published by FP 50 Featherstone Street London EC1Y 8U Tel: 020 7608 5240 Fax: 0845 123 2349 www.fpa.org.uk The
More informationEmergency Contraception THE FACTS
Emergency Contraception Quick Facts What is it? Emergency contraception is birth control that you use after you have had unprotected sex--if you didn t use birth control or your regular birth control failed.
More informationUnit 9 CONTRACEPTION LEARNING OBJECTIVES
Unit 9 CONTRACEPTION LEARNING OBJECTIVES 1. Become aware of the magnitude of teen age sexual activity and pregnancy and some of the social and economic effects. 2. Learn about the various means of contraception,
More informationBirth Control Options Chart
Hormonal Methods Birth control pills also known as mini-pills 91-99% A daily pill containing hormones that stops you from ovulating. There are combination estrogen or progestin-only (mini-pill) options.
More informationNotes to Teacher continued Contraceptive Considerations
Abstinence a conscious decision to refrain from sexual intercourse 100% pregnancy will not occur if close contact between the penis and vagina does not take place. The risk of a number of STDs, including
More informationFitting of an Intrauterine Device (IUD)
PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is an IUD? An IUD is a small T-shaped plastic and copper device that is put into
More informationLONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables
LONG-ACTING REVERSIBLE CONTRACEPTION Summary Tables Bridging the Divide: A Project of the Jacobs Institute of Women s Health June 2016 Table 1. Summary of LARC Methods Available Years Since Effective Copper
More information17. Preventing pregnancy
17. Preventing pregnancy Objectives By the end of this session, group members will be able to: Define contraception. List ways young people can prevent pregnancy. Background notes What is contraception?
More informationIncreasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland
Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland Dr Audrey Brown Dr Alison Bigrigg Greater Glasgow and Clyde Long-acting reversible
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationThrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor
Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service
More informationDay of Learning: Current Best Practices for Contraceptive Provision
Day of Learning: Current Best Practices for Contraceptive Provision Thank you to our Sponsors Carnegie Science Center Jewish Healthcare Foundation Allegheny Health Network s Center for Inclusion Health
More informationGlobal Contraception
Video Companion Guide Global Contraception Learning Objectives: By the end of the session, learners will be able to: Describe of all contraceptive methods. Develop a basic understanding of patient-centered
More informationContraception and Kidney Problems: Advice for Young Adults
Contraception and Kidney Problems: Advice for Young Adults Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationThe Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial A Multi-Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women using Depot Medroxyprogesterone
More informationBirth Control in Patients with Congenital Heart Disease
Birth Control in Patients with Congenital Heart Disease Arwa Saidi MB. BCh. MEd. FACC University of Florida Departments of Pediatrics and Internal Medicine Gainesville, FL There are an increasing number
More informationFast Facts. Fast Facts: Contraception. Ailsa E Gebbie and Katharine O Connell White Third edition Health Press Ltd.
Fast Facts Fast Facts: Contraception Ailsa E Gebbie and Katharine O Connell White Third edition Fast Facts Fast Facts: Contraception Third edition Ailsa E Gebbie MB ChB FRCOG FFSRH Consultant Gynecologist
More informationInformation for Informed Consent for Insertion of a Mirena IUD
Information for Informed Consent for Insertion of a Mirena IUD What is an IUD (intrauterine Device)? An intrauterine device (IUD) is a plastic device that is placed into your uterus to prevent pregnancy.
More informationLong-Acting Reversible Contraception: The Contraceptive CHOICE Project
Long-Acting Reversible Contraception: The Contraceptive CHOICE Project Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research Robert J. Terry Professor Department of Obstetrics & Gynecology Washington
More informationCONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK
CONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK Global figures Women account for 51.6% of HIV globally (15.9m of 30.8m HIV+ adults) UNAIDS report on the global AIDS epidemic, 2010 Estimated no.
More informationComplex Cases Birmingham 6 th October Dr Nicola Mullin FFSRH FRCOG Consultant in Sexual & Reproductive Health, Chester
Complex Cases Birmingham 6 th October 2018 Dr Nicola Mullin FFSRH FRCOG Consultant in Sexual & Reproductive Health, Chester Declaration of interest I have received remuneration for some lectures and support
More informationMEDICAL POLICY SUBJECT: FEMALE STERILIZATION. POLICY NUMBER: CATEGORY: Contract Clarification
MEDICAL POLICY SUBJECT: FEMALE STERILIZATION PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More information